FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
R-Zero Raises $15M in New Capital: To Accelerate Production and Deployment of its Flagship IoT UV-C System
R-Zero notes the $15M Series A round of financing was led by DBL Partners, one of the largest pioneering and leading impact investors, with participation from Bedrock Capital and HAX / SOSV.
Eko Raises $65 Million in Series C Funding to Close the Gap Between Virtual and In-Person Heart and Lung Care
The new funding will be used to expand in-clinic use of the company’s platform of telehealth and AI algorithms for disease screening, and to launch a monitoring program for cardiopulmonary patients at home.
Fountain Healthcare Partners Announces Final Close of €125 Million for Fund III
The €125 million capital raised was sourced from major domestic and international institutional investors, including fund of funds, sovereign funds, corporate investors and family offices.
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The company notes employees received, in the aggregate, options to purchase 20,835 shares of Sarepta's common stock, and in the aggregate, 8,385 restricted stock units.
Shoulder Innovations Reports Equity Financing of $21.6M
The fundraising was led by US Venture Partners together with Lightstone Ventures, also included participation by Alumni Venture Partners, Wakestream Ventures, Biosciences Research, and Commercialization Center of Western Michigan University, Invest Michigan, and the Michigan Angel Fund, among others.
Advanced Chemotherapy Technologies Achieves $5.5M Series A Financing: Company to Pursue First Clinical Trials of ACT-IOP-003 Targeting Advanced Pancreatic Cancer
The capital will be used to fund initial clinical development of the company’s ACT-IOP-003 local chemotherapy system for the treatment of locally advanced non-resectable and borderline resectable pancreatic cancer.
One Health Company Secures $10M In New Financing
The new financing will enable One Health Company to accelerate the expansion of its flagship product, FidoCure®, in a time where pets are increasingly family members and demand for pet care solutions has boomed.
Sidekick Health Raises $20M in Series A Funding
Sidekick Health specializes in the creation of gamified digital therapeutic solutions and programs, transforming chronic and lifestyle disease management across multiple therapeutic areas, ranging from diabetes to ulcerative colitis and smoking cessation.
ABM Respiratory Care Raises $10.3M in Series A Funding Round: Company to Advance Commercialization in the US
The company also announced the appointment of Peter H. Soderberg as Chairman of the company's Board of Directors.
Medical Device News Magazine
